ArticleEJNMMI research2025
The impact of patient hydration and forced diuresis on [
Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prostate-specific Membrane Antigen-PET/CT in Nonprostatic Malignancies: Potential Applications in Theranostics.Clinical nuclear medicine · 2026Review
- Comparison of urinary bladder activity from [EJNMMI reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background[18F]PSMA-1007 has minimal renal excretion, allowing for better assessment of the pelvic area in patients with prostate cancer (PCa). Nevertheless, there have been instances of notably high [18F]PSMA-1007 uptake in the urinary bladder. The purpose of this study was to assess the impact of preliminary patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake.
resultsА prospective single-center study included 185 patients with PCa, who underwent [18F]PSMA-1007 PET/CT. Patients were divided into 11 groups: a control group with no specific preparation (n = 35) and 10 experimental groups (n = 15 in each) with different preparation protocols, that included oral or IV hydration and/or furosemide administration. LBM SUVmean was used to quantify [18F]PSMA-1007 bladder uptake. The differences in bladder SUVmean among the different preparation groups, as well as compared to the control group, were evaluated. A p-value < 0.001 was considered statistically significant. Additionally, the variability of bladder SUVmean was assessed by evaluating the interquartile ranges (IQRs). The results indicate that the application of furosemide significantly reduced the median and variability of bladder SUVmean (p < 0.001), 30 min time interval of furosemide application prior to PET scan is preferable compared to 90 min interval (p < 0.001). Hydration alone, without furosemide, was insufficient for effectively reducing the median and variability of bladder SUVmean (p = 0.5). There was no significant difference between the groups with different routes and volumes of hydration (p = 0.03 and 0.45).
conclusionForced diuresis is an effective tool for reducing the [18F]PSMA-1007 urinary bladder uptake and its variability when it is routinely increased. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.